For example, it has been found that the palmitoylation of epidermal growth factor receptor (EGFR) can induce tyrosine kinase inhibitor gefitinib resistance in non-small cell lung cancer (NSCLC) (Ali et al., 2018). This evidence concerns the gene EGFR and non-small cell lung carcinoma.